Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
17
LFWD Quote, Financials, Valuation and Earnings
Last price:
$0.74
Seasonality move
:
-15.26%
Day range:
$0.70 - $0.76
52-week range:
$0.50 - $4.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.27x
P/B ratio:
0.44x
Volume:
392.1K
Avg. volume:
1.2M
1-year change:
-81.17%
Market cap:
$8.1M
Revenue:
$25.7M
EPS (TTM):
-$3.04
Analysts' Opinion
-
Consensus RatingLifeward has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.67, Lifeward has an estimated upside of 1071.17% from its current price of $0.74.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $3.00 representing 100% downside risk from its current price of $0.74.
Fair Value
-
According to the consensus of 1 analyst, Lifeward has 1071.17% upside to fair value with a price target of $8.67 per share.
LFWD vs. S&P 500
-
Over the past 5 trading days, Lifeward has underperformed the S&P 500 by -3.96% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lifeward does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lifeward revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Lifeward reported revenues of $5M.
Earnings Growth
-
Lifeward has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Lifeward reported earnings per share of -$0.46.
Enterprise value:
2.4M
EV / Invested capital:
--
Price / LTM sales:
0.27x
EV / EBIT:
--
EV / Revenue:
0.10x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
-0.12x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$8.9M
Return On Assets:
-65.08%
Net Income Margin (TTM):
-108.21%
Return On Equity:
-92.59%
Return On Invested Capital:
-92.59%
Operating Margin:
-96.4%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $5.9M | $17.9M | $25.4M | $5.3M | $5M | |
| Gross Profit | $2.2M | $5.3M | $8.9M | $1.4M | $2.1M | |
| Operating Income | -$19.2M | -$25.7M | -$17.9M | -$6.5M | -$4.9M | |
| EBITDA | -$19M | -$23M | -$14.9M | -$5.5M | -$4.8M | |
| Diluted EPS | -$2.26 | -$3.07 | -$3.04 | -$0.73 | -$0.46 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $71.9M | $87.8M | $66.9M | $32.8M | $19.8M | |
| Total Assets | $74.6M | $90M | $69M | $55.2M | $28.8M | |
| Current Liabilities | $4M | $3.6M | $3.9M | $10.1M | $9.1M | |
| Total Liabilities | $5.5M | $4.8M | $5.5M | $14.6M | $10.4M | |
| Total Equity | $69M | $85.2M | $63.5M | $40.6M | $18.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$17.4M | -$23.1M | -$19.5M | -$7.7M | -$5.5M | |
| Cash From Investing | -$22K | -- | -- | -- | -$5K | |
| Cash From Financing | -$3.3M | -$221K | $4.5M | -- | $4.5M | |
| Free Cash Flow | -$17.4M | -$23.2M | -$19.5M | -$7.7M | -$5.5M | |
LFWD
Sector
Market Cap
$8.1M
$34.4M
Price % of 52-Week High
15.51%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-24.74%
-1.01%
1-Year Price Total Return
-81.17%
-37.36%
Beta (5-Year)
0.016
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.74
200-day SMA
Sell
Level
$1.70
Bollinger Bands (100)
Sell
Level
0.98 - 1.66
Chaikin Money Flow
Sell
Level
-126.8M
20-day SMA
Sell
Level
$0.77
Relative Strength Index (RSI14)
Sell
Level
37.35
ADX Line
Sell
Level
34.38
Williams %R
Neutral
Level
-48.0022
50-day SMA
Sell
Level
$1.07
MACD (12, 26)
Sell
Level
-0.10
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
170.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.2145)
Sell
CA Score
(Annual)
Level (-1.2245)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (6.1699)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
Stock Forecast FAQ
In the current month, LFWD has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LFWD average analyst price target in the past 3 months is $8.67.
-
Where Will Lifeward Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lifeward share price will rise to $8.67 per share over the next 12 months.
-
What Do Analysts Say About Lifeward?
Analysts are divided on their view about Lifeward share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lifeward is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is Lifeward's Price Target?
The price target for Lifeward over the next 1-year time period is forecast to be $8.67 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LFWD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lifeward is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of LFWD?
You can purchase shares of Lifeward via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lifeward shares.
-
What Is The Lifeward Share Price Today?
Lifeward was last trading at $0.74 per share. This represents the most recent stock quote for Lifeward. Yesterday, Lifeward closed at $0.74 per share.
-
How To Buy Lifeward Stock Online?
In order to purchase Lifeward stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
